Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
116 Street Ventures is a venture capital firm that operates as part of the Alumni Ventures network, specifically serving the Columbia University community. The firm provides accredited alumni and friends of the university with the opportunity to invest in a diversified portfolio of high-growth startups, including many in the biotechnology, pharmaceutical, and healthcare sectors. 116 Street Ventures typically co-invests alongside established venture capital firms in seed through growth-stage rounds. By leveraging the extensive Columbia alumni network, the firm identifies promising innovations and provides strategic support to its portfolio companies. Its investment strategy emphasizes sector diversification while maintaining a strong presence in life science and technology-driven industries. The firm aims to democratize access to venture capital for individual investors while fostering entrepreneurship within the Columbia ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 116 Street Ventures.